Last reviewed 2026-04-20 · How we verify

Anti-TNF suspended perioperatively

CHU de Quebec-Universite Laval · FDA-approved active Small molecule Quality 0/100

Anti-TNF suspended perioperatively is a Small molecule drug developed by CHU de Quebec-Universite Laval. It is currently FDA-approved. Also known as: Infliximab, Remicade, Etanercept, Enbrel.

Anti-TNF, marketed by CHU de Quebec-Universite Laval, is a suspension used perioperatively in patients requiring temporary discontinuation of anti-TNF therapy. The drug's key strength lies in its unique mechanism of action and specific perioperative use, which differentiates it from continuous treatment options. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.

At a glance

Generic name	Anti-TNF suspended perioperatively
Also known as	Infliximab, Remicade, Etanercept, Enbrel, Adalimumab
Sponsor	CHU de Quebec-Universite Laval
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Anti-TNF suspended perioperatively CI brief — competitive landscape report
Anti-TNF suspended perioperatively updates RSS · CI watch RSS
CHU de Quebec-Universite Laval portfolio CI

Frequently asked questions about Anti-TNF suspended perioperatively

What is Anti-TNF suspended perioperatively?

Anti-TNF suspended perioperatively is a Small molecule drug developed by CHU de Quebec-Universite Laval.

Who makes Anti-TNF suspended perioperatively?

Anti-TNF suspended perioperatively is developed and marketed by CHU de Quebec-Universite Laval (see full CHU de Quebec-Universite Laval pipeline at /company/chu-de-quebec-universite-laval).

Is Anti-TNF suspended perioperatively also known as anything else?

Anti-TNF suspended perioperatively is also known as Infliximab, Remicade, Etanercept, Enbrel, Adalimumab.

What development phase is Anti-TNF suspended perioperatively in?

Anti-TNF suspended perioperatively is FDA-approved (marketed).

Manufacturer: CHU de Quebec-Universite Laval — full pipeline
Also known as: Infliximab, Remicade, Etanercept, Enbrel, Adalimumab